Evidence map›Paper›PMID 38603446›Full record

ArticleSimulation2023

Simulation modeling assessment and improvement of a COVID-19 mass vaccination center operations.

Abdessalem Jerbi, Faouzi Masmoudi

Abstract read
In one paragraph

Article in Simulation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abdessalem JerbiLaboratoire Optimisation, Logistique et Informatique Décisionnelle (OLID), LR19ES21, Institut Supérieur de Gestion Industrielle de Sfax, Université de Sfax, Tunisia.ORCID https://orcid.org/0000-0001-5039-7278
Faouzi MasmoudiMechanics, Modelling and Production Research Laboratory (LA2MP), National Engineering School of Sfax (ENIS), University of Sfax, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of safe and effective vaccines against COVID-19 has been a turning point in the international effort to control this disease. However, vaccine development is only the first phase of the COVID-19 vaccination process. Correct planning of mass vaccination is important for any policy to immunize the population. For this purpose, it is necessary to set up and properly manage mass vaccination centers. This paper presents a discrete event simulation model of a real COVID-19 mass vaccination center located in Sfax, Tunisia. This model was used to evaluate the management of this center through different performance measures. Three person's arrival scenarios were considered and simulated to verify the response of this real vaccination center to arrival variability. A second model was proposed and simulated to improve the performances of the vaccination center. Like the first model, this one underwent the same evaluation process through the three arrivals scenarios. The simulation results show that both models respond well to the arrival's variability. Indeed, most of the arriving persons are vaccinated on time for all the studied scenarios. In addition, both models present moderate average vaccination and waiting times. However, the average utilization rates of operators are modest and need to be improved. Furthermore, both simulation models show a high average number of persons present in the vaccination center, which goes against the respect of the social distancing condition. Comparison between the two simulation models shows that the proposed model is more efficient than the actual one.

Indexed as

COVID-19Discrete event simulationmass vaccination centerpublic health simulation

Identifiers

PMID38603446
PMCPMC9679319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.